The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism
2017 · Journal of Biological Chemistry · 93 citations
https://doi.org/10.1074/jbc.m117.813923
M
Molly A. Silvers
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
625
Citations
8
h-index
8
i10-index
Molly A. Silvers is an academic researcher from Harold C. Simmons Comprehensive Cancer Center. The author has contributed to research in topics: Bioactive Compounds and Antitumor Agents & Cancer therapeutics and mechanisms & Computational Drug Discovery Methods. The author has an h-index of 8, co-authored 12 publications.
ORCID: 0000-0001-5544-8329Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat